Evidence map›Paper›PMID 24978934›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2014

Intrinsically radiolabeled nanoparticles: an emerging paradigm.

Shreya Goel, Feng Chen, Emily B Ehlerding, Weibo Cai

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Development ofJournal of nanobiotechnology · 2024
    Article
  7. [Molecules (Basel, Switzerland) · 2024
    Review
  8. Review
  9. Review
  10. Nanomaterial-based contrast agents.Nature reviews. Methods primers · 2023
    Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Image-guided mathematical modeling for pharmacological evaluation of nanomaterials and monoclonal antibodies.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2020
    Review
  16. Article
  17. Article
  18. Marriage of black phosphorus and CuNature communications · 2020
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shreya GoelMaterials Science Program, University of Wisconsin-Madison, 1509 University Avenue Madison, WI, 53706-15952, USA.
Feng Chen
Emily B Ehlerding
Weibo Cai

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI AMY TRENTHAM-DIETZ · 1985 to 2026
$142.6M
Novel Combination Therapy for Prostate CancerR01CA169365 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI CAI, WEIBO · 2013 to 2015
$903k
NCI NIH HHS 1R01CA169365NCI NIH HHS P30 CA014520NCI NIH HHS P30CA014520NCI NIH HHS R01 CA169365
6 · The paper itself

Abstract

Although chelator-based radiolabeling techniques have been used for decades, concerns about the complexity of coordination chemistry, possible altering of pharmacokinetics of carriers, and potential detachment of radioisotopes during imaging have driven the need for developing a simple yet better technique for future radiolabeling. Here, the emerging concept of intrinsically radiolabeled nanoparticles, which could be synthesized using methods such as hot-plus-cold precursors, specific trapping, cation exchange, and proton beam activation, is introduced. Representative examples of using these multifunctional nanoparticles for multimodality molecular imaging are highlighted together with current challenges and future research directions. Although still in the early stages, design and synthesis of intrinsically radiolabeled nanoparticles has shown attractive potential to offer easier, faster, and more specific radiolabeling possibilities for the next generation of molecular imaging.

Indexed as

CationsChelating AgentsCrystallizationHumansMicroscopy, Electron, TransmissionMultimodal ImagingNanoparticlesNanotechnologyNeoplasmsPositron-Emission TomographyProtonsRadioisotopesTomography, Emission-Computed, Single-PhotonCationsChelating AgentsProtonsRadioisotopeschelator-freeIntrinsic radiolabelingmultimodality imagingnanomaterialspositron emission tomographysingle photon emission computed tomography

Identifiers

PMID24978934
PMCPMC4191998

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.